Press Releases

  • VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock

  • VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock

  • VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

  • VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board

  • VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update

  • VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update

  • VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer

  • VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.

  • VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone

arrow-downarrow-leftarrow-rightarrowchevron-downcircle-link--redcircle-linkcloseplayplus